MGF regulation of fatty acid β-oxidation metabolism could further be experimentally validated in human HT29 colon cancer cells by colorimetric detection of decrease in β-hydroxybutyrate concentrations and protein expression of the key metabolic enzyme CPT1. This evidence concerns the gene CPT1A and colonic neoplasm.